Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker DGX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 650 | $257.34 | $167.3K Sale | Form 4 ↗ |
| Nov 9, 2026 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 6,793 | $257.34 | $1.7M Sale | Form 4 ↗ |
| Nov 9, 2026 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 4,274 | $257.34 | $1.1M Sale | Form 4 ↗ |
| Nov 3, 2026 | Catherine T. Doherty Executive Vice President | DGX Quest Diagnostics Incorporated | Sale | 2,907 | $251.24 | $730.4K Sale | Form 4 ↗ |
| Nov 3, 2026 | Catherine T. Doherty Executive Vice President | DGX Quest Diagnostics Incorporated | Sale | 2,877 | $250.49 | $720.7K Sale | Form 4 ↗ |
| Nov 3, 2026 | Catherine T. Doherty Executive Vice President | DGX Quest Diagnostics Incorporated | Sale | 3,004 | $249.40 | $749.2K Sale | Form 4 ↗ |
| Nov 3, 2026 | Catherine T. Doherty Executive Vice President | DGX Quest Diagnostics Incorporated | Sale | 2,358 | $248.38 | $585.7K Sale | Form 4 ↗ |
| Nov 3, 2026 | Catherine T. Doherty Executive Vice President | DGX Quest Diagnostics Incorporated | Sale | 1,151 | $246.98 | $284.3K Sale | Form 4 ↗ |
| Nov 3, 2026 | Catherine T. Doherty Executive Vice President | DGX Quest Diagnostics Incorporated | Sale | 5,990 | $246.26 | $1.5M Sale | Form 4 ↗ |
| Nov 3, 2026 | Catherine T. Doherty Executive Vice President | DGX Quest Diagnostics Incorporated | Sale | 3,818 | $245.45 | $937.1K Sale | Form 4 ↗ |
| Oct 26, 2026 | Gary M. Pfeiffer Director | DGX Quest Diagnostics Incorporated | Sale | 1,203 | $243.00 | $292.3K Sale | Form 4 ↗ |
| Sep 1, 2026 | J. E. Davis CEO and President, Director | DGX Quest Diagnostics Incorporated | Sale | 10,000 | $242.72 | $2.4M Sale | Form 4 ↗ |
| Aug 28, 2026 | Michael E. Prevoznik SVP & General Counsel | DGX Quest Diagnostics Incorporated | Sale | 430 | $244.51 | $105.1K Sale | Form 4 ↗ |
| Aug 28, 2026 | Michael E. Prevoznik SVP & General Counsel | DGX Quest Diagnostics Incorporated | Sale | 6,237 | $243.63 | $1.5M Sale | Form 4 ↗ |
| Aug 28, 2026 | Michael E. Prevoznik SVP & General Counsel | DGX Quest Diagnostics Incorporated | Sale | 16,010 | $242.88 | $3.9M Sale | Form 4 ↗ |
| Jul 28, 2026 | Mark E. Delaney SVP & Chief Commercial Officer | DGX Quest Diagnostics Incorporated | Sale | 1,600 | $235.18 | $376.3K Sale | Form 4 ↗ |
| Jun 4, 2026 | Karthik Kuppusamy SVP, Clinical Solutions | DGX Quest Diagnostics Incorporated | Sale | 8,147 | $200.00 | $1.6M Sale | Form 4 ↗ |
| Jun 1, 2026 | J. E. Davis CEO and President, Director | DGX Quest Diagnostics Incorporated | Sale | 10,000 | $194.14 | $1.9M Sale | Form 4 ↗ |
| Mar 5, 2026 | Catherine T. Doherty EVP, Regional Businesses | DGX Quest Diagnostics Incorporated | Sale | 5,558 | $206.21 | $1.1M Sale | Form 4 ↗ |
| Mar 5, 2026 | Michael E. Prevoznik SVP & General Counsel | DGX Quest Diagnostics Incorporated | Sale | 3,878 | $206.21 | $799.7K Sale | Form 4 ↗ |
| Mar 5, 2026 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 2,855 | $206.21 | $588.7K Sale | Form 4 ↗ |
| Mar 4, 2026 | Karthik Kuppusamy SVP, Clinical Solutions | DGX Quest Diagnostics Incorporated | Sale | 2,628 | $204.86 | $538.4K Sale | Form 4 ↗ |
| Mar 3, 2026 | Catherine T. Doherty EVP, Regional Businesses | DGX Quest Diagnostics Incorporated | Sale | 632 | $207.73 | $131.3K Sale | Form 4 ↗ |
| Mar 3, 2026 | Michael E. Prevoznik SVP & General Counsel | DGX Quest Diagnostics Incorporated | Sale | 526 | $207.73 | $109.3K Sale | Form 4 ↗ |
| Mar 3, 2026 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 410 | $207.73 | $85.2K Sale | Form 4 ↗ |
| Mar 2, 2026 | J. E. Davis CEO and President, Director | DGX Quest Diagnostics Incorporated | Sale | 10,000 | $212.52 | $2.1M Sale | Form 4 ↗ |
| Feb 19, 2026 | Catherine T. Doherty EVP, Regional Businesses | DGX Quest Diagnostics Incorporated | Sale | 1,433 | $204.83 | $293.5K Sale | Form 4 ↗ |
| Feb 19, 2026 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 958 | $204.83 | $196.2K Sale | Form 4 ↗ |
| Feb 19, 2026 | Michael E. Prevoznik SVP & General Counsel | DGX Quest Diagnostics Incorporated | Sale | 1,111 | $204.83 | $227.6K Sale | Form 4 ↗ |
| Feb 13, 2026 | Catherine T. Doherty EVP, Regional Businesses | DGX Quest Diagnostics Incorporated | Sale | 351 | $209.10 | $73.4K Sale | Form 4 ↗ |
| Feb 13, 2026 | Catherine T. Doherty EVP, Regional Businesses | DGX Quest Diagnostics Incorporated | Sale | 1,619 | $208.21 | $337.1K Sale | Form 4 ↗ |
| Feb 13, 2026 | Catherine T. Doherty EVP, Regional Businesses | DGX Quest Diagnostics Incorporated | Sale | 3,500 | $207.08 | $724.8K Sale | Form 4 ↗ |
| Feb 13, 2026 | Catherine T. Doherty EVP, Regional Businesses | DGX Quest Diagnostics Incorporated | Sale | 10,122 | $206.37 | $2.1M Sale | Form 4 ↗ |
| Feb 13, 2026 | Catherine T. Doherty EVP, Regional Businesses | DGX Quest Diagnostics Incorporated | Sale | 10,573 | $205.21 | $2.2M Sale | Form 4 ↗ |
| Feb 10, 2026 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 5,662 | $204.00 | $1.2M Sale | Form 4 ↗ |
| Nov 25, 2025 | J. E. Davis CEO and President, Director | DGX Quest Diagnostics Incorporated | Sale | 4,747 | $192.97 | $916.0K Sale | Form 4 ↗ |
| Nov 25, 2025 | J. E. Davis CEO and President, Director | DGX Quest Diagnostics Incorporated | Sale | 41,004 | $192.27 | $7.9M Sale | Form 4 ↗ |
| Nov 25, 2025 | J. E. Davis CEO and President, Director | DGX Quest Diagnostics Incorporated | Sale | 9,342 | $191.59 | $1.8M Sale | Form 4 ↗ |
| Nov 25, 2025 | Vicky B. Gregg Director | DGX Quest Diagnostics Incorporated | Sale | 1,250 | $191.76 | $239.7K Sale | Form 4 ↗ |
| Nov 18, 2025 | Mark E. Delaney SVP & Chief Commercial Officer | DGX Quest Diagnostics Incorporated | Sale | 7,946 | $187.35 | $1.5M Sale | Form 4 ↗ |
| Oct 22, 2025 | Gary M. Pfeiffer Director | DGX Quest Diagnostics Incorporated | Sale | 1,482 | $182.40 | $270.3K Sale | Form 4 ↗ |
| Sep 26, 2025 | Michael E. Prevoznik SVP & General Counsel | DGX Quest Diagnostics Incorporated | Sale | 144 | $188.66 | $27.2K Sale | Form 4 ↗ |
| Sep 26, 2025 | Michael E. Prevoznik SVP & General Counsel | DGX Quest Diagnostics Incorporated | Sale | 83 | $187.22 | $15.5K Sale | Form 4 ↗ |
| Sep 24, 2025 | Michael E. Prevoznik SVP & General Counsel | DGX Quest Diagnostics Incorporated | Sale | 175 | $187.02 | $32.7K Sale | Form 4 ↗ |
| Sep 23, 2025 | Michael E. Prevoznik SVP & General Counsel | DGX Quest Diagnostics Incorporated | Sale | 28,288 | $187.12 | $5.3M Sale | Form 4 ↗ |
| Aug 21, 2025 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 1,975 | $185.00 | $365.4K Sale | Form 4 ↗ |
| Aug 19, 2025 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 4,532 | $183.00 | $829.4K Sale | Form 4 ↗ |
| Aug 15, 2025 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 1,975 | $180.00 | $355.5K Sale | Form 4 ↗ |
| Aug 6, 2025 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 1,975 | $175.00 | $345.6K Sale | Form 4 ↗ |
| Aug 6, 2025 | Patrick Plewman SVP for Diagnostic Services | DGX Quest Diagnostics Incorporated | Sale | 3,560 | $175.00 | $623.0K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:15 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances